Empagliflozin Tablets
Empagliflozin tablets for type 2 diabetes and heart failure. They lower blood sugar by letting the kidneys remove it in urine.
- Category
- Diabetes Management
- Active ingredient
- Empagliflozin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg · 25mg
A generic with the stated active ingredient and strength. The maker is confirmed before dispatch.
Supply requirements for Empagliflozin Tablets depend on the medicine and destination. The fulfilment partner must confirm them before accepting an order.
Empagliflozin Tablets details
- Alternative names
- jardiance
- Therapeutic class
- Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
- Pharmacological class
- SGLT2 Inhibitor
- Known off-label uses
- chronic kidney disease
- Contraindications
- severe renal impairment (for glycaemic control); diabetic ketoacidosis
- Minor side effects
- increased urination; nausea
- Moderate side effects
- urinary tract infection; genital fungal infection; dyslipidaemia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Insulin; Diuretics
- Age restrictions
- Approved for adults.
Serious side effects
fournier's gangrene, requires immediate medical attention; diabetic ketoacidosis, requires immediate medical attention
Patient summary
Empagliflozin tablets for type 2 diabetes and heart failure. They lower blood sugar by letting the kidneys remove it in urine.
Mechanism of action
Blocks SGLT2 in renal proximal tubules, lowering glucose reabsorption so that excess blood sugar is lost through urination.
Pregnancy and breastfeeding
Pregnancy: Avoid during second and third trimesters. Breastfeeding: Not recommended.
What you will receive
Empagliflozin Tablets is a generic, listed by its active ingredient, Empagliflozin.
- The maker is confirmed before dispatch.
- Check the active ingredient, strength, form, pack, seal, batch and expiry details.